References
Price FW Jr, Price MO (2013) Evolution of endothelial keratoplasty. Cornea 32(Suppl 1):S28–S32
Heindl LM, Riss S, Bachmann BO, Laaser K, Kruse FE, Cursiefen C (2011) Split cornea transplantation for 2 recipients: a new strategy to reduce corneal tissue cost and shortage. Ophthalmology 118:294–301
Lie JT, Groeneveld-van Beek EA, Ham L, van der Wees J, Melles GR (2010) More efficient use of donor corneal tissue with Descemet membrane endothelial keratoplasty (DMEK): two lamellar keratoplasty procedures with one donor cornea. Br J Ophthalmol 94:1265–1266
Heindl LM, Riss S, Laaser K, Bachmann BO, Kruse FE, Cursiefen C (2011) Split cornea transplantation for 2 recipients - review of the first 100 consecutive patients. Am J Ophthalmol 152:523–532
Heindl LM, Riss S, Adler W, Bucher F, Hos D, Cursiefen C (2013) Split cornea transplantation: relationship between storage time of split donor tissue and outcome. Ophthalmology 120:899–907
Heindl LM, Riss S, Adler W, Steven P, Hos D, Cursiefen C (2013) Corneal graft alterations after Descemet stripping: implications for split cornea transplantation. JAMA Ophthalmol 131:687–689
Schaub F, Cursiefen C, Heindl L (2015) Retrospective appraisal of split cornea transplantation - an audit of 1,141 donor corneas. JAMA Ophthalmol 133:1086–1087
Russell FM, Biribo SS, Selvaraj G, Oppedisano F, Warren S, Seduadua A, Mulholland EK, Carapetis JR (2006) As a bacterial culture medium, citrated sheep blood agar is a practical alternative to citrated human blood agar in laboratories of developing countries. J Clin Microbiol 44:3346–3351
Yucesoy M, Esen N, Yulug N (2001) Use of chromogenic tube and methyl blue-sabouraud agar for the identification of Candida albicans strains. Kobe J Med Sci 47:161–167
Barenfanger J, Drake C, Kacich G (1999) Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol 37:1415–1418
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This research was supported by German Research Foundation FOR 2240 “(Lymph) Angiogenesis And Cellular Immunity In Inflammatory Diseases Of The Eye” to CC and LMH, GEROK Program University of Cologne to LMH, Dr. Gabriele Lederle-Foundation, Taufkirchen to LMH, and EU COST BM1302 “Joining Forces in Corneal Regeneration” to CC. The sponsor had no role in the design or implementation of this research.
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual next relatives of cornea tissue donors included in this study according to German transplantation law.
Rights and permissions
About this article
Cite this article
Schaub, F., Enders, P., Cursiefen, C. et al. Split-cornea transplantation — a microbiologically safe approach?. Graefes Arch Clin Exp Ophthalmol 254, 1441–1442 (2016). https://doi.org/10.1007/s00417-016-3324-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-016-3324-z